A landmark Phase 3 clinical trial is beginning in the UK, testing whether a common cough medicine can be used to treat Parkinson’s disease. The rare genetic disorder leaves people deficient in an enzyme called glucocerebrosidase (or GCase). Screening hundreds of already approved drugs, researchers discovered a common ingredient in cough syrup called ambroxol increased […]